Total: 13 results found.

Search for:
Search Only:

1. FAQs
(FAQs)
... when the tumor burden is still minimal and the radiation therapy can be most effective. Download this article by Doctors Grabowski and Baum for more explanation. Can I be on Octreotide therapy during ...
Created on 13 April 2011
2. Information for Referring Physicians
(General MD)
... by OctreoScan or (preferable) by Ga-68 DOTATOC PET/CT. * Renal function and blood counts should be in the normal range. * Small bowel tumors (midgut), progressive under octreotide (Sandostatin, Somatuline) ...
Created on 19 July 2010
3. Food, Dining, Medications and Personal Gear Considerations
(What to bring)
... enough medication to last for the duration of their stay. Typically, all medications related to the PRRT are included in the fee for the treatment. If the patient is using the Subq form of Octreotide ...
Created on 19 July 2010
4. Medical Records and Information Needed
(Prior Tests)
... CT, MRI, Octreotide scans or PSMA-Gallium-68 scans that should exist on CD or DVDs. Depending upon a patient's case history, some historical records could be needed as well. Dr. Baum normally will advise ...
Created on 19 July 2010
5. J. Reynolds - PRRT Bad Berka
(Bad Berka)
... type, I was also not going to sit idly by and let someone else coordinate my medical care and I still refuse to do that. After establishing care with oncology and being started on Octreotide LAR injections, ...
Created on 01 March 2017
6. Results from NETTER-1 PRRT Trail Released
(News)
The results from the first randomized control trial of PRRT were released today in Vienna, Austria showing increased progression free survival compared to high dose octreotide LAR. PRRT while available ...
Created on 27 September 2015
7. Becca H
(Rotterdam)
... taking a stool softener with you (Senokot S is especially good), in case you need it. It’s also advisable to take pain meds with you, just in case you need them. You’ll need to take your Octreotide subcutaneous ...
Created on 26 February 2014
8. PRRT Multi-Center Trial Now Open
(In the News)
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours (NETTER-1) is now open ...
Created on 21 July 2013
9. Multicenter PRRT Clinical Trial Announced
(In the News)
... parallel-group phase III study. In this study, treatment with 177Lu-DOTA0-Tyr3-Octreotate plus best supportive care (30 mg Octreotide LAR) will be compared to treatment with high dose (60 mg) Octreotide ...
Created on 20 April 2012
10. CCAN NET Cancer Patients Conference Long Island
(Past Conferences )
... in New Orleans Dr. Tom O’Dorisio – University of Iowa Evolution of NETs –  from Gastrin in 1905 – Zollinger-Ellison 1955- Radio Peptide Receptor 1967  - Octreotide 1980 - to Theranostics (Baum) ...
Created on 20 August 2011
11. A Soldier's Stor
(Bad Berka)
... Barnes Jewish Hospital in St. Louis, Missouri. My new doctor there ordered several tests for me including the Octreotide scan, CT scan, and blood tests. My tumors were confirmed as Carcinoid with high ...
Created on 31 May 2011
12. Flora
(Bad Berka)
... and some suggested waiting and watching the disease since a medication called octreotide controlled all of Flora's symptoms. Most surgeons felt that Flora's cancer was inoperable because there were too many ...
Created on 18 April 2011
13. 1st World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy
(In the News)
... diarrhea; weight gain in underweight patients; the ability to give up octreotide therapy; and improvement of overall health. Most importantly, the median overall survival of patients from the start of ...
Created on 07 April 2011